Therapeutics
Davide Dalla Costa, MD
Dr.
ASST Grande Ospedale Metropolitano Niguarda
Milan, Lombardia, Italy
Patrizia Sgabussi, MS
Physioterapist
ASST Grande Ospedale Metropolitano Niguarda
Milan, Lombardia, Italy
Vincenzo Morello, MS
Physioterapist
ASST Grande Ospedale Metropolitano Niguarda
Milan, Lombardia, Italy
Antonella Citterio, MD
Dr.
ASST Grande Ospedale Metropolitano Niguarda
Milan, Lombardia, Italy
This was a retrospective, observational, two-arm case–control study. Patients were enrolled from January 2022 and followed in a dedicated scar clinic. All patients underwent enzymatic debridement within 72 hours of injury. Forty days after wound healing, treatment was initiated in hypertrophic areas and continued for six months. Subjects were divided into 2 groups (n=10): A, the protocol (gel applied daily and plaster nightly), and B, the control (emollient moisturizer). Pressure garments were used constantly. Scar outcomes were assessed using the Vancouver Scar Scale (VSS) and Patient and Observer Scar Assessment Scale (POSAS) at 3, 6, and 12 months.
Results: